Jijun Dong

Company: Salubris

Job title: Chief Scientific Officer

Seminars:

Deep Diving into Cardiac Fibrosis & Novel Therapeutic Mechanisms Capable of Remodelling Fibrotic Features 10:00 am

Exploring the role of the NRG/ErbB4 pathway in cardiac regeneration Examining NRG-1 growth factor in myocardial development, homeostasis, and repair, and its potential for reversing fibrotic features in heart failure Exploring preclinical data showing remodelling of fibrosis in animal modelsRead more

day: Day Two

Examining Cross Disease Insights into Advanced Biomarker Strategies for Antifibrotic Drug Development 11:05 am

This interactive workshop offers exclusive insights from experts across various fields including renal, hepatic, cardiac, pulmonary, scleroderma, gastrointestinal and cross[1]fibrosis diseases. Addressing the most critical biomarker challenges facing antifibrotic drug developers from ensuring biomarkers are specific, sensitive, and validated across different patient populations and disease stages to non-invasive markers of progression and therapeutic efficacy. Capitalize…Read more

day: Pre-Conference Day